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Implications of the Kidd blood group system in 
renal transplantation
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RepoRt
The association of the Kidd blood group system with hemolytic 
transfusion reactions and hemolytic disease of the newborn 
is well known. The Kidd antigens, which are localized to the 
HUT/UT-B urea transport protein, are found on red blood cells 
and the endothelial cells of the blood vessels of the medulla of 
the kidney. Recently it has been suggested that these antigens 
might play a role as minor histocompatibility antigens in renal 
transplantation. In the current case, the appearance of an anti-Jkb 
10 years after renal transplantation associated with early renal 
allograft rejection further supports the potential importance of 
these antigens in renal transplantation and allograft rejection. 
Immunohematology 2012;28:91–4.
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The Kidd blood group antigens Jka and Jkb are expressed 
at position 280 of the membrane glycoprotein HUT11/UT-B. 
This protein is thought to function as a urea transporter that 
protects the red blood cell (RBC) from osmotic gradients, 
particularly as it passes through the kidney.1 The UT-B protein 
has also been localized to endothelial cells of the vasa recta of 
the medulla of the kidney where it facilitates the excretion of 
urea and concentration of the urine.2 More recently, the UT-B 
protein has been identified in a variety of other tissues such as 
testis3 and colon.4
Antibodies to Jka and Jkb have been associated with both 
hemolytic transfusion reactions (HTR) and hemolytic disease 
of the fetus and newborn (HDFN). More recently, they have 
also been associated with several cases of acute or delayed renal 
allograft rejection.5 We report a case in which the appearance 
of anti-Jkb is associated with early renal allograft rejection 
more than 10 years after the initial renal transplant surgery.
Case Report
At 14 months of age, an African American boy was treated 
for pneumonia caused by Streptococcus pneumoniae and 
associated hemolytic uremic syndrome (HUS). At that time, 
the patient received five group O+ RBC transfusions and one 
group O+ platelet transfusion; his antibody screen remained 
negative throughout the 8 days of his hospitalization. The 
patient was discharged from the hospital but, as a result of 
progressive renal disease, required peritoneal dialysis 48 
months later. He did well on dialysis for 4 months but then 
underwent an uncomplicated cadaveric renal transplant 
procedure requiring no transfusions. For approximately 
10 years, the patient did well and was maintained on a 
routine immunosuppressive regimen including tacrolimus, 
mycophenolate, and prednisone. Then, during a routine follow-
up visit, he was found to have a slightly elevated creatinine (1.7 
mg/dL compared with his usual baseline of 1.2 mg/dL). On 
further questioning, he admitted to oliguria and to “missing 
several doses” of his immunosuppressive medications. In 
preparation for a renal biopsy, a blood type and antibody 
screen was performed. His blood type was confirmed as O+, 
but for the first time his antibody screen was strongly positive 
(3+); anti-Jkb was identified. Kidney biopsy was consistent 
with acute allograft rejection, Banff classification type IA, 
plasma cell rich.6 The patient’s immunosuppressive regimen 
was reestablished while he was in the hospital, and now, 7 
months later, his creatinine has returned to his usual baseline 
and his antibody screen is again negative.
Materials and Methods
Current blood type and antibody identification were 
performed by solid-phase red blood cell adherence assay using 
the Galileo immunohematology analyzer (Immucor Gamma, 
Norcross, GA).
Results
During the course of the patient’s treatment for HUS at the 
age of 14 months, he received 5 group O+ RBC transfusions 
and one group O+ platelet transfusion. His antibody screen at 
this time remained negative during the 8 days during which 
he was transfused. No further blood type or antibody screen 
was performed until the time of his renal transplant procedure 
48 months later; his antibody screen at that time continued 
to be negative and he received no transfusions during or after 
this surgical procedure. The patient was routinely evaluated 
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during the subsequent 10 years and apparently was doing well 
until, at the time of a routine follow-up visit, he was found to 
have an elevated creatinine level. When the patient admitted 
to oliguria and failing to adhere to his immunosuppressive 
regimen, a renal biopsy was scheduled. In preparation for this 
procedure, an antibody screen was performed and was found 
to be strongly positive (3+). The antibody was identified as 
anti-Jkb. Table 1 summarizes these results. The renal biopsy 
(Fig. 1) was considered diagnostic of acute allograft rejection 
(Banff type IA, plasma cell rich).
Discussion
Antibodies to the Kidd blood group antigens, Jka and Jkb, 
are well known to cause HTR and HDFN. However, recently 
a small number of reports have also suggested the importance 
of these antibodies in renal transplantation. The importance 
of these antibodies in renal transplantation presumably arises 
from the fact that the protein carrying the Kidd antigens, 
referred to as UT-B, is expressed on both the RBC membrane 
and the endothelial cells of the vasa recta of the medulla of the 
kidney.7
We report a case of renal allograft rejection occurring 10 
years after transplantation. Transplant rejection in this case 
was heralded by a slight rise in serum creatinine and was 
probably related to the patient’s recent poor compliance with 
his immunosuppressive medications. Unexpectedly, anti-Jkb 
was identified when a routine blood type and antibody screen 
was performed in preparation for the renal biopsy. Because the 
patient had only been transfused with RBCs approximately 10 
years before the appearance of anti-Jkb and had had a negative 
antibody screen during that period, it seems safe to assume 
that the transplanted kidney stimulated the development of this 
antibody. It is also important to note that the antibody appeared 
at a time when the patient admitted to poor compliance with 
his immunosuppressive medications. It is possible that anti-
Jkb first appeared in this patient at the time of his transfusions 
at the age of 14 months and the reappearance of the antibody 
10 years later is simply an anamnestic response to the exposure 
to the Jkb antigen presumably present on the transplanted 
kidney. Alternatively, it seems possible that the Kidd antigen on 
the transplanted kidney stimulated the de novo development 
of the antibody once the patient’s immunosuppressive regimen 
was interrupted. This observation is supported by several 
recent case reports.
In one of these, Hamilton et al.8 report the case of a 
19-year-old woman who underwent a cadaveric kidney 
transplant procedure owing to a diagnosis of focal segmental 
glomerulosclerosis. The patient was noncompliant with her 
immunosuppressive medications, and approximately 24 
months after her transplant she exhibited renal failure that 
ultimately necessitated dialysis and transplant nephrectomy. 
During her hospitalization she was found to have a positive 
antibody screen, and anti-Jkb was identified. Because this 
patient had no history of blood transfusion or pregnancy, the 
authors hypothesized that the antigen on the transplanted 
Table 1. Summary of patient information
Date Purpose Antibody screen Antibody identification Transfusion Creatinine
Nov. 1996 Treatment; HUS Negative 5 RBC, 1 platelet Not available
Dec. 2000 Clinic visit; follow-up Negative None Not available
April 2001 Hospitalization; pre-renal transplant Negative None Not available
Aug. 10, 2010 Clinic visit; follow-up Not Done None 1.7 mg/dL
Aug. 13, 2010 Hospitalization; treatment of acute rejection Positive Anti-Jkb None 1.5 mg/dL
Aug. 15, 2010 Hospital discharge Not Done None 1.6 mg/dL
March 2011 Clinic visit; follow-up Negative None 1.3 mg/dL
HUS = hemolytic uremic syndrome; RBC = red blood cell.
Fig. 1 Photomicrograph of kidney biopsy specimen demonstrates 
a prominent inflammatory infiltrate with prominent plasma cells 
consistent with Banff type 1 acute rejection, plasma cell rich.
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kidney served as the immunizing antigen causing the 
development of the anti-Jkb. In this case, a diagnosis of plasma 
cell-rich acute cellular rejection (PCAR) was made by renal 
biopsy. It has been suggested that in PCAR, which is a rather 
uncommon inflammatory manifestation of allograft rejection, 
patient-derived plasma cells infiltrate the renal allograft and 
are responsible for the production of antibody in situ.9 Hamilton 
et al.8 make the suggestion that the anti-Jkb was synthesized 
by the plasma cells identified in the kidney. Hamilton et al.10 
described another 19-year-old woman who exhibited anti-
Jka 7 years after renal transplantation. Again, the patient 
was described as noncompliant with her immunosuppressive 
regimen. In this case, however, at the time of original renal 
transplantation the patient received two units of RBCs that 
were known to be Jk(a+).
In each of these three cases a cadaveric renal transplant 
was carried out on a patient with a negative antibody screen and 
2 to 10 years later, in a setting of noncompliance with a routine 
immunosuppressive regimen, an antibody to the Kidd blood 
group system (anti-Jka or anti-Jkb) appeared in conjunction 
with acute kidney transplant rejection. A comparison of these 
cases is found in Table 2.
The critical role that antibodies of the Kidd system 
may play in renal allograft rejection is further suggested by 
Holt et al.11 In this case a 29-year-old patient experienced a 
hyperacute renal allograft rejection presumably caused by a 
complement-fixing anti-Jka. In this case it was suspected that 
the patient had developed anti-Jka as a result of a series of RBC 
transfusions that she had received approximately 18 years 
earlier. After her renal transplant procedure, she received 
three units of RBCs. Within 2 hours of this transfusion, the 
patient exhibited a fever and urine output slowed. Eventually 
the direct antiglobulin test was found to be positive, and an 
eluate demonstrated anti-Jka. The authors suggested that the 
transfusions shortly after her renal transplant stimulated an 
anamnestic anti-Jka, which was then responsible for both the 
transfusion reaction and ultimately failure of her graft.
Lerut et al.5 compared the matching versus mismatching 
status for Kidd and Duffy polymorphisms in 370 consecutive 
kidney transplants. With respect to the Kidd antigens, 
those transplants in which the donor and recipient were 
mismatched for Kidd antigens showed a greater degree of 
interstitial inflammation than those cases in which the donor 
and recipient were matched, thus suggesting the potential 
importance of these antigens in clinical transplantation.
Clearly, then, each of these case reports supports the 
suggestion that Kidd antigens do, in fact, act as minor 
histocompatibility antigens that are uncommon but potentially 
important causes of renal allograft rejection. Functionally, the 
explanation for this lies in the observation that the protein 
carrying the Kidd antigens derives from a single gene and is 
found on both the RBC and the endothelial cells of the vasa 
recta of the medulla of the kidney. The question that remains 
in the current case is whether the Kidd antigens on the 
transplanted kidney served as the primary stimulus for the 
development of the Jkb antibody (as suggested by the report 
of Hamilton et al.8) or whether it served as the stimulus for 
an anamnestic antibody response of an anti-Jkb that originally 
arose because of the RBC transfusions 10 years earlier. In either 
event the important effect of the Kidd antigens on the kidney 
is apparent as the transplanted kidney must have either served 
as an immunogen in stimulating an anamnestic development 
of anti-Jka or been the primary immunizing agent.
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